Concord Medical Services Holding Ltd. ADR Stock

$5.85

4.17% day before yesterday

NYSE, Sep 06, 10:10 pm CET

ISIN

US2062771058

Symbol

CCM

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

Concord Medical Services Holding Ltd. ADR Stock price

$5.85

-18.46 75.95% 5Y

NYSE, Closing price Fri, Sep 06 2024

+0.23 4.17%

ISIN

US2062771058

Symbol

CCM

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Health service provider

Key metrics

Market capitalization	$16.46m
Enterprise Value	$1.01b
P/E (TTM) P/E ratio	negative
EV/Sales (TTM) EV/Sales	13.34
P/S ratio (TTM) P/S ratio	0.22
P/B ratio (TTM) P/B ratio	negative
Revenue growth (TTM) Revenue growth	9.80%
Revenue (TTM) Revenue	$75.99m
EBIT (operating result TTM) EBIT	$-65.28m
EPS (TTM) EPS	$-9.58
Short interest	0.85%

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Get Started for Free Today

Concord Medical Services Holding Ltd. ADR Stock Analysis

Unlock Scores for Free

??

Financial data from Concord Medical Services Holding Ltd. ADR

Income Statement P&L | Balance Sheet | Cash Flow

TTM Annually

Dec '23		+/- %
Revenue	76 76	10% 10% 100%
- Direct Costs	87 87	6% 6% 114%
Gross Profit	-11 -11	53% 53% -14%
- Selling and Administrative Expenses	36 36	3% 3% 48%
- Research and Development Expense	- -	- -
EBITDA	-47 -47	19% 19% -62%
- Depreciation and Amortization	18 18	8% 8% 24%
EBIT (Operating Income) EBIT	-65 -65	16% 16% -86%
Net Profit	-42 -42	42% 42% -55%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Concord Medical Services Holding Ltd. ADR Stock News

Neutral

PRNewsWire

●

about one month ago

Concord Medical Regains Compliance with NYSE Minimum Price Requirement

BEIJING , Aug. 7, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter from the New York Stock Exchange ("NYSE") dated August 6, 2024 (the "Compliance Notice"), notifying the Company that it ...

Neutral

Business Wire

●

about 2 months ago

Canagold Intercepts Strong Mineralization in First Five Resource Expansion Drill Holes at New Polaris

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) announces sample assay results from the first five drill holes from the resource expansion drill program targeting the North Zone at its 100% owned New Polaris Gold project located in northwestern British Columbia, 100 kilometers (km) south of Atlin and 60 km nor...

Neutral

PRNewsWire

●

about 2 months ago

CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE

BEIJING , July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it plans to change the ratio of its American depositary shares ("ADSs") to Class A ordinary shares (the "ADS Ratio") from the current ADS Ratio ...

More Concord Medical Services Holding Ltd. ADR News

Company Profile

Concord Medical Services Holding Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. It provides radiotherapy and diagnostic equipment leasing services to hospitals; and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals, It operates through Network Business and Hospital Business segments. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Head office	Cayman Islands
CEO	Jianyu Yang
Employees	727
Founded	2007
Website	www.concordmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now